Veronica Mariotti

Oncology
12902 Usf Magnolia Dr
Tampa, FL 33612

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.

A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.

Journal: JCO precision oncology
Published: May 04, 2023

Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.

Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.

Journal: Aging
Published: March 01, 2023

Emerging immunotherapeutic strategies for the treatment of breast cancer.

Emerging immunotherapeutic strategies for the treatment of breast cancer.

Journal: Breast cancer research and treatment
Published: March 19, 2021

Strategies to Combat Human Epidermal Growth Factor Receptor 2 (HER2) Resistance in HER2-Positive Breast Cancer.

Strategies to Combat Human Epidermal Growth Factor Receptor 2 (HER2) Resistance in HER2-Positive Breast Cancer.

Journal: Critical reviews in oncogenesis
Published: January 19, 2021

Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial.

Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial.

Journal: JAMA oncology
Published: November 05, 2020

Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.

Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 18, 2020

Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score.

Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score.

Journal: Journal of bone oncology
Published: July 20, 2016

Mesenchymal stromal/stem cells in drug therapy: New perspective.

Mesenchymal stromal/stem cells in drug therapy: New perspective.

Journal: Cytotherapy
Published: April 09, 2016

Stem cell in alternative treatments for brain tumors: potential for gene delivery.

Stem cell in alternative treatments for brain tumors: potential for gene delivery.

Journal: Molecular and cellular therapies
Published: January 01, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026